Reaction equation
Cl[CH2:2][CH:3]1[CH2:9][N:8]([CH3:10])[C:7](=[O:11])[C:6]2[CH:12]=[CH:13][CH:14]=[N:15][C:5]=2[O:4]1.ClCCC1[CH2:25][N:24](C)[C:23](=O)C2C=CC=NC=2O1>>[CH3:23][N:24]([CH2:2][CH:3]1[CH2:9][N:8]([CH3:10])[C:7](=[O:11])[C:6]2[CH:12]=[CH:13][CH:14]=[N:15][C:5]=2[O:4]1)[CH3:25]Participants
3
Procedure
When in the procedure of Example 10, 2-chloromethyl-2,3-dihydro-4-methylpyrido[3,2-f][1,4]-oxazepin-5(4H)-one is substituted for 2-(2-chloroethyl)-2,3-dihydro-4-methylpyrido[3,2-f][1,4]-oxazepin-5(4H)-one, the title compound is prepared and is isolated if desired as a pharmaceutically acceptable salt.
Workup
- customis isolated
Sources & evidence
- ORD record
- ord-f2ced41ca80546fca5cc841a48e387ac
- Source dataset
- uspto-grants-1988_02
- Patent number
- US04727152
Linked notes
Loading…